<DOC>
	<DOCNO>NCT01241669</DOCNO>
	<brief_summary>This drug-drug interaction study evaluate effect steady-state exposure E5555 main metabolite pharmacokinetics ( PK ) metformin , organic cation transporter-2 ( OCT2 ) substrate . In addition , study also investigate effect E5555 several renal function parameter .</brief_summary>
	<brief_title>Randomized , Placebo-controlled Study Evaluate Effects E5555 Renal Function Parameters OCT2 Activity</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>Healthy male female subject age great equal 18 year 55 year History medical condition result increase risk bleed include limited active recurrent gastric ulcer , recent head trauma surgery , severe hypertension , bacterial endocarditis , etc . Creatinine clearance &lt; 90 mL/min estimate use CockcroftGault formula screen baseline History renal disorder , proteinuria , hepatobiliary disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>